Brief Report: Relationship Between Serum Infliximab Concentrations and Risk of Infections in Patients Treated for Spondyloarthritis

Theodora Bejan-Angoulvant; David Ternant; Fadela Daoued; Frédéric Medina; Louis Bernard; Saloua Mammou; Gilles Paintaud; Denis Mulleman

doi:10.1002/art.39841

Journal articles

Brief Report: Relationship Between Serum Infliximab Concentrations and Risk of Infections in Patients Treated for Spondyloarthritis

Theodora Bejan-Angoulvant ¹ David Ternant ¹ Fadela Daoued Frédéric Medina Louis Bernard ² Saloua Mammou Gilles Paintaud ¹ Denis Mulleman ¹

1 GICC UMR 7292 CNRS - Génétique, immunothérapie, chimie et cancer (GICC), UMR 7292 CNRS [2012-2017]

2 Service des Maladies Infectieuses

Abstract : Tumor necrosis factor inhibitors are effective in reducing inflammation in rheumatic diseases but increase the risk of infections. This study was undertaken to investigate the relationship between the trough serum concentration of infliximab (IFX) and the risk of a first infection episode.

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Human health and pathology

Life Sciences [q-bio] / Human health and pathology / Rhumatology and musculoskeletal system

Life Sciences [q-bio] / Human health and pathology / Infectious diseases

Life Sciences [q-bio] / Pharmaceutical sciences / Pharmacology

Complete list of metadatas

https://hal-univ-tours.archives-ouvertes.fr/hal-01980809
Contributor : Denis Mulleman <>
Submitted on : Monday, January 14, 2019 - 4:39:31 PM
Last modification on : Wednesday, December 4, 2019 - 2:38:03 PM

Brief Report: Relationship Between Serum Infliximab Concentrations and Risk of Infections in Patients Treated for Spondyloarthritis

Identifiers

Collections

Citation

Export

Metrics

95

Brief Report: Relationship Between Serum Infliximab Concentrations and Risk of Infections in Patients Treated for Spondyloarthritis

Identifiers

Collections

Citation

Export

Share

Metrics

95